市场调查报告书
商品编码
1423648
微导管的全球市场预测(-2030):按产品类型、设计、应用、最终用户和地区进行分析Microcatheters Market Forecasts to 2030 - Global Analysis By Product Type, By Design, Application, End User and By Geography |
2023年全球微导管市场规模为8.542亿美元,预计2030年将达到13.538亿美元,预测期内复合年增长率为6.8%。微导管是细的柔性管,直径通常为 3 毫米或更小,专为微创医疗手术而设计。
应用范围从介入放射学中复杂血管结构的导航到治疗剂和栓塞剂的精确传递。
根据美国卫生统计中心的数据,美国每年有超过 795,000 人中风。此外,根据日本国家癌症中心癌症控制资讯中心的数据,2020 年大约确认了 1,012,000 例癌症病例。
微创手术增加
随着医疗实践转向侵入性较小的干预措施,微导管在精确进入复杂的解剖结构方面发挥着至关重要的作用。这些纤细、灵活的导管有利于小血管的导航,使医疗专业人员能够提供治疗药物、进行诊断性血管造影术并进行各种血管介入治疗,同时对周围组织造成的创伤最小。我们将为您提供支持。对微导管的需求是由对更快的患者恢復时间、更少的併发症和更高的手术精度的偏好偏好的,这使得它们成为介入医学发展的重要工具,并有助于改善患者的治疗结果。
开发和製造成本高
复杂的设计、精密的工程以及先进材料的使用导致了高昂的製造成本。微导管的开发需要最尖端科技和对细节的一丝不苟,而且製造过程本身就很复杂。此外,遵守法规和遵守严格的品质标准也会增加成本负担。这些高成本为市场进入带来了挑战,并限制了医疗保健提供者和患者对微导管的承受能力。製造商面临着平衡创新和品质保证的需求与提供具有成本效益的解决方案的需求之间的困境。
门诊医疗日益受到重视
门诊护理因其成本效益、患者便利性以及在传统医院环境之外执行各种医疗程序的能力而受到关注。微导管在向门诊医疗的转变中发挥着重要作用,因为它们允许在血管和其他医疗应用中进行微创诊断和治疗性介入。微导管的弹性、精确性和导航能力使其适合在门诊环境中使用,在门诊环境中,早期復健和缩短住院时间是首要任务。
医疗预算紧张和成本限制
世界各地的卫生系统都受到财政限制的困扰,这可能会阻碍微导管等创新且可能昂贵的医疗设备的引入。开发微导管需要复杂的技术和精度,这可能导致更高的製造成本和更高的价格。在医疗保健提供者面临优化支出压力的地区,这尤其具有挑战性。此外,与替代治疗方法相比,微导管的成本较高,可能会导致医疗机构选择更经济的选择,进而影响市场渗透率。
COVID-19 的爆发对微导管市场产生了多方面的影响。由于医疗资源的重新分配和安全问题,包括使用微导管的某些干预措施在内的选择性手术暂时下降,但随着非紧急服务的恢復,市场已经恢復。此次疫情凸显了微创手术的重要性,随着医疗保健系统优先考虑高效和微创手术,推动了对微导管的需求。然而,供应链中断、择期手术延误和经济不确定性也给大流行期间的微导管市场带来了挑战。
预计循环系统在预测期内将是最大的
循环系统在微导管市场中占有很大份额。由于其细长的特性和增强的导航性,微导管使医生能够精确地进入复杂的血管途径,支持冠动脉摄影术、血管成形术和栓塞手术。心血管疾病盛行率的上升和对微创技术的日益偏好正在推动对心血管微导管的需求。持续的技术创新和不断扩大的老年人口正在推动介入心臟病学领域诊断和治疗能力的提高,进一步促进市场成长。
医院和诊所部门在预测期内的复合年增长率最高
预测期内微导管市场复合年增长率最高的是医院和诊所。在这些医疗机构中,微导管广泛用于各种介入手术,例如血管造影术、栓塞和血管介入治疗。心血管疾病盛行率的上升和微创手术的成长趋势推动了需求。微导管使医疗专业人员能够精确地导航复杂的血管结构,减少患者创伤并改善手术结果。这些设备的持续采用证实了它们在改善医院和诊所的患者照护以及推进介入医学的重要性。
北美由于其先进的医疗保健和基础设施、技术创新以及心血管疾病的高盛行率而占据重要地位,预计在预测期内将保持最大份额。微创治疗的不断增长趋势和需要血管介入治疗的人口老化正在推动对微导管的需求。此外,积极的研发活动以及与医疗机构和产业参与者的策略联盟有助于微导管技术的持续发展。随着法律规范的建立和医疗专业人员意识的不断提高,北美仍然是微导管进步和市场成长的关键中心。
由于微创手术的快速增加、心血管疾病盛行率的上升以及医疗基础设施的开拓,亚太地区的微导管市场复合年增长率最高。不断增长的老年人口,特别是在日本和中国等国家,进一步推动了介入性心臟病学和血管介入治疗领域对微导管的需求。医疗技术的进步,加上人们对微创技术优势的认识不断提高,正在促进市场的扩张。国内外製造商之间的合作也有助于促进创新和市场渗透。
According to Stratistics MRC, the Global Microcatheters Market is accounted for $854.2 million in 2023 and is expected to reach $1353.8 million by 2030 growing at a CAGR of 6.8% during the forecast period. The Microcatheters are thin, flexible tubes with diameters typically less than 3 millimeters, designed for minimally invasive medical procedures. Their uses range from navigating complex vascular structures in interventional radiology to delivering therapeutic agents or embolic materials precisely.
According to the National Center for Health Statistics, every year, more than 795,000 people in the U.S. have a stroke. According to Center for Cancer Control and Information Services, a part of National Cancer Center, Japan, approximately 1,012,000 cases of cancer were noticed in 2020.
Growing minimally invasive procedures
Medical practices shift towards less invasive interventions, microcatheters play a pivotal role in enabling precise access to intricate anatomical structures. These thin and flexible catheters facilitate the navigation of narrow vessels, aiding healthcare professionals in delivering therapeutic agents, performing diagnostic angiography, and conducting various vascular interventions with minimal trauma to surrounding tissues. The demand for microcatheters is propelled by the preference for reduced patient recovery times, fewer complications, and enhanced procedural precision, making them indispensable tools in the evolving landscape of interventional medicine and contributing to improved patient outcomes.
High development and manufacturing costs
The intricate design, precision engineering, and the use of advanced materials contribute to elevated production expenses. The development of microcatheters requires cutting-edge technologies and meticulous attention to detail, making the manufacturing process inherently complex. Moreover, regulatory compliance and adherence to stringent quality standards further contribute to the cost burden. These high costs can pose challenges for market accessibility, limiting the affordability of microcatheters for both healthcare institutions and patients. Manufacturers face the dilemma of balancing the need for technological innovation and quality assurance with the necessity to offer cost-effective solutions.
Increasing focus on ambulatory care
Ambulatory or outpatient care settings are gaining prominence due to their cost-effectiveness, patient convenience, and the ability to perform various medical procedures outside traditional hospital environments. Microcatheters play a crucial role in the shift towards ambulatory care, as they enable minimally invasive procedures for diagnostic and therapeutic interventions in vascular and other medical applications. The flexibility, precision, and navigational capabilities of microcatheters make them well-suited for use in outpatient settings, where quick recovery and reduced hospital stays are prioritized.
Stringent healthcare budgets and cost constraints
Healthcare systems globally grapple with financial limitations, the adoption of innovative and potentially more expensive medical devices like microcatheters may be impeded. The intricate technology and precision involved in microcatheter development contribute to higher production costs, potentially leading to elevated prices. This can be particularly challenging in regions where healthcare providers are under pressure to optimize expenditures. Moreover, as microcatheters are perceived as costlier compared to alternative treatment methods, healthcare facilities may opt for more economical options, impacting market penetration.
The COVID-19 pandemic has had a multifaceted impact on the microcatheters market. While elective procedures, including certain interventions using microcatheters, experienced temporary declines due to healthcare resource reallocation and safety concerns, the market witnessed a subsequent rebound with the resumption of non-emergency medical services. The pandemic underscored the importance of minimally invasive procedures, boosting the demand for microcatheters as healthcare systems prioritized efficient and less invasive interventions. However, supply chain disruptions, delays in elective procedures, and economic uncertainties have also posed challenges to the microcatheters market during the pandemic.
The cardiovascular is expected to be the largest during the forecast period
The cardiovascular has a significant share in the Microcatheters market. With their slender profiles and enhanced navigability, microcatheters enable physicians to access intricate vascular pathways with precision, supporting procedures such as coronary angiography, angioplasty, and embolization. The rising incidence of cardiovascular diseases, coupled with a growing preference for minimally invasive techniques, propels the demand for cardiovascular microcatheters. Ongoing technological innovations and the expanding geriatric population further contribute to the market's growth, fostering improved diagnostic and therapeutic capabilities in the field of cardiovascular interventions.
The hospitals and clinics segment is expected to have the highest CAGR during the forecast period
The hospitals and clinics have the highest CAGR within the Microcatheters market over the forecast period. These medical facilities extensively utilize microcatheters in various interventional procedures, such as angiography, embolization, and vascular interventions. The demand is driven by the rising prevalence of cardiovascular diseases and the increasing trend toward minimally invasive surgeries. Microcatheters enable healthcare professionals to navigate complex vascular structures with precision, reducing patient trauma and enhancing procedural outcomes. The continual adoption of these devices underscores their importance in improving patient care and advancing the field of interventional medicine within hospital and clinic settings.
North America holds a significant position and expected to hold a largest share over the forecast period due to the region's advanced healthcare infrastructure, technological innovation, and a high prevalence of cardiovascular diseases. The growing trend toward minimally invasive procedures, coupled with an aging population requiring vascular interventions, has propelled the demand for microcatheters. Furthermore, robust research and development activities and strategic collaborations between healthcare institutions and industry players contribute to the continuous evolution of microcatheter technologies. With a well-established regulatory framework and increasing awareness among healthcare professionals, North America remains a key hub for microcatheter advancements and market growth.
The Asia-Pacific region witnessed the highest CAGR in the Microcatheters market due to a surge in minimally invasive procedures, a rising prevalence of cardiovascular diseases, and increasing healthcare infrastructure development. The expanding geriatric population, particularly in countries like Japan and China, further propels the demand for microcatheters in interventional cardiology and vascular interventions. Advancements in healthcare technologies, coupled with a growing awareness of the benefits of minimally invasive techniques, contribute to the market's expansion. Collaborations between local and international manufacturers also play a role in fostering innovation and market penetration.
Key players in the market
Some of the key players in Microcatheters Market include Abbott Laboratories, Inc., Becton, Dickinson and Company, Terumo Corporation, Boston Scientific Corporation, Cardinal Health, Inc., Cardiovascular Systems, Johnson & Johnson, Teleflex Corporation, Medtronic PLC, Stryker Corporation and Merit Medical Systems, Inc.
In October 2023, Johnson & Johnson signed an agreement to acquire Abiomed, a medical device technology company. This acquisition broadens Johnson & Johnson's offerings as well as helps patients.
In July 2023, Stryker announced the acquisition of Vocera Communications, Inc., a company engaged in digital care communication and coordination. Through this acquisition, Vocera provides a supportive and advanced suite to Stryker's Medical division that would improve Stryker's Advanced Digital Healthcare suite and accelerate Stryker's focus on preventing adverse events across the cycle of care.
In December 2022, Boston Scientific Corporation announced the acquisition of Acotec Scientific Holdings Limited, a prominent Chinese medical technology company catering innovative solutions for several interventional procedures. This development has strengthened the company's operating capabilities in the market.